Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium-Reference-Cited by-同舟云学术

Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium

Published:2015-01-31 Issue:1 Volume:15 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Tops Bastiaan BJ,Normanno Nicola,Kurth Henriette,Amato Eliana,Mafficini Andrea,Rieber Nora,Le Corre Delphine,Rachiglio Anna Maria,Reiman Anne,Sheils Orla,Noppen Christoph,Lacroix Ludovic,Cree Ian A,Scarpa Aldo,Ligtenberg Marjolijn JL,Laurent-Puig Pierre

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/article/10.1186/s12885-015-1015-5/fulltext.html

Reference22 articles.

1. Mendelsohn J. Personalizing oncology: perspectives and prospects. J Clin Oncol. 2013;31(15):1904–11.

2. Douillard J-Y, Oliner KS, Siena S, Tabernero J, Burkes R, Barugel M, et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med. 2013;369(11):1023–34.

3. Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009;361(10):947–57.

4. Normanno N, Rachiglio AM, Roma C, Fenizia F, Esposito C, Pasquale R, et al. Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities. J Cell Biochem. 2013;114(3):514–24.

5. Garraway LA. Genomics-Driven Oncology: Framework for an Emerging Paradigm. J Clin Oncol. 2013;31(15):1806–14.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing;Cancer Treatment Reviews;2024-01

2. Development of a somatic variant registry in a National Cancer Center: towards Molecular Real World Data preparedness;Journal of Biomedical Informatics;2023-06

3. Circulating tumor DNA: a help to guide therapeutic strategy in patients with borderline and locally advanced pancreatic adenocarcinoma?;Digestive and Liver Disease;2022-10

4. The emerging roles of NGS in clinical oncology and personalized medicine;Pathology - Research and Practice;2022-02

5. Poor performance status patient with long-lasting major response to pembrolizumab in advanced non-small-cell lung cancer with coexisting POLE mutation and deficient mismatch repair pathway;Lung Cancer;2021-10